GLP-1 / Metabolic
Sema-1
GLP-1 Agonist
$69.00
Size
Out of stock
Description
GLP-1 receptor agonist analog. Extensively studied in metabolic and glycemic research.
Research
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist with approximately 94% sequence homology to native human GLP-1. Research demonstrates potent glucose-dependent insulin secretion stimulation, glucagon suppression, and delayed gastric emptying. Preclinical and clinical studies have shown significant reductions in HbA1c and body weight in metabolic disease models. Mechanistic research indicates semaglutide acts on hypothalamic appetite centers to reduce caloric intake. Studies also suggest cardiovascular benefits, including reduced major adverse cardiac events in high-risk populations. Ongoing research explores its potential in non-alcoholic steatohepatitis (NASH), Alzheimer's disease models, and addiction pathways. For research use only.
RESEARCH USE ONLY. Not for human or veterinary consumption. This product is sold to qualified researchers aged 21 or older for laboratory research purposes.